BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16133529)

  • 1. The MMP-9 expression determined the efficacy of postoperative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer.
    Ogata Y; Matono K; Sasatomi T; Ishibashi N; Ohkita A; Mizobe T; Ogo S; Ikeda S; Ozasa H; Shirouzu K
    Cancer Chemother Pharmacol; 2006 May; 57(5):577-83. PubMed ID: 16133529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of vascular endothelial growth factor determines the efficacy of post-operative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer.
    Ogata Y; Matono K; Mizobe T; Ishibashi N; Mori S; Akagi Y; Ikeda S; Ozasa H; Murakami H; Shirouzu K
    Oncol Rep; 2006 May; 15(5):1111-6. PubMed ID: 16596171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral fluoropyrimidines may not reduce the risk of postoperative recurrence in colorectal cancer associated with mesenteric lymph node metastasis.
    Ogata Y; Torigoe S; Matono K; Sasatomi T; Ishibashi N; Shida S; Ohkita A; Fukumitu T; Mizobe T; Ikeda S; Ogo S; Ozasa H; Shirouzu K
    Int Surg; 2007; 92(6):314-9. PubMed ID: 18402123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised phase III trial of adjuvant chemotherapy with oral uracil and tegafur plus leucovorin versus intravenous fluorouracil and levofolinate in patients with stage III colorectal cancer who have undergone Japanese D2/D3 lymph node dissection: final results of JCOG0205.
    Shimada Y; Hamaguchi T; Mizusawa J; Saito N; Kanemitsu Y; Takiguchi N; Ohue M; Kato T; Takii Y; Sato T; Tomita N; Yamaguchi S; Akaike M; Mishima H; Kubo Y; Nakamura K; Fukuda H; Moriya Y
    Eur J Cancer; 2014 Sep; 50(13):2231-40. PubMed ID: 24958736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indication and efficacy of adjuvant chemotherapy with oral fluoropyrimidines for dukes' B colorectal cancer.
    Yoshimatsu K; Umehara A; Ishibashi K; Yokomizo H; Yoshida K; Fujimoto T; Watanabe K; Ogawa K
    Anticancer Res; 2006; 26(4B):3089-93. PubMed ID: 16886639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An anticancer drug sensitivity test to determine the effectiveness of UFT as postoperative adjuvant chemotherapy for patients with stage III colorectal cancer.
    Isogai A; Nagaya M; Matsuoka H; Watanabe T; Tsukikawa S; Kubota S
    Surgery; 2007 Nov; 142(5):741-8. PubMed ID: 17981195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter randomized prospective study of adjuvant chemotherapy with UFT and mitomycin C in advanced colorectal cancer.
    Nakagoe T; Ishikawa H; Sawai T; Tuji T; Ayabe H; Eida K; Nogawa T; Nakamura Y; Kunisaki T; Tobinaga K; Furukawa M; Ino M
    Anticancer Res; 2000; 20(2B):1069-75. PubMed ID: 10810399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors predicting the response to oral fluoropyrimidine drugs: a phase II trial on the individualization of postoperative adjuvant chemotherapy using oral fluorinated pyrimidines in stage III colorectal cancer treated by curative resection (ACT-01 Study).
    Mori T; Ohue M; Takii Y; Hashizume T; Kato T; Kotake K; Sato T; Tango T
    Oncol Rep; 2013 Feb; 29(2):437-44. PubMed ID: 23232805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomised-controlled trial of 1-year adjuvant chemotherapy with oral tegafur-uracil versus surgery alone in stage II colon cancer: SACURA trial.
    Matsuda C; Ishiguro M; Teramukai S; Kajiwara Y; Fujii S; Kinugasa Y; Nakamoto Y; Kotake M; Sakamoto Y; Kurachi K; Maeda A; Komori K; Tomita N; Shimada Y; Takahashi K; Kotake K; Watanabe M; Mochizuki H; Nakagawa Y; Sugihara K;
    Eur J Cancer; 2018 Jun; 96():54-63. PubMed ID: 29677641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy increase survival and decrease recurrence in stage IIA colon cancer.
    Yun HR; Kim HC; Yun SH; Lee WY
    Hepatogastroenterology; 2012; 59(120):2466-71. PubMed ID: 23169179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant chemotherapy with uracil-tegafur for pathological stage III rectal cancer after mesorectal excision with selective lateral pelvic lymphadenectomy: a multicenter randomized controlled trial.
    Akasu T; Moriya Y; Ohashi Y; Yoshida S; Shirao K; Kodaira S;
    Jpn J Clin Oncol; 2006 Apr; 36(4):237-44. PubMed ID: 16675478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of postoperative UFT (Tegafur/Uracil) plus PSK therapies in elderly patients with resected colorectal cancer.
    Yoshitani S; Takashima S
    Cancer Biother Radiopharm; 2009 Feb; 24(1):35-40. PubMed ID: 19243246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using preoperative UFT to predict sensitivity to fluoropyrimidines in colorectal cancer.
    Fujii M
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):55-60. PubMed ID: 10442363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of the Postoperative Adjuvant Chemotherapy with UFT/LV or Capecitabine for Stage III Colorectal Cancer].
    Maruyama T; Yasuda K; Sako A; Ueda K; Okumura M
    Gan To Kagaku Ryoho; 2016 Jan; 43(1):69-72. PubMed ID: 26809528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of systemic and regional chemotherapy after hepatic resection for colorectal metastases.
    Kokudo N; Seki M; Ohta H; Azekura K; Ueno M; Sato T; Moroguchi A; Matsubara T; Takahashi T; Nakajima T; Aiba K
    Ann Surg Oncol; 1998 Dec; 5(8):706-12. PubMed ID: 9869517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefit of Adjuvant Chemotherapy After Curative Resection of Lung Metastasis in Colorectal Cancer.
    Park HS; Jung M; Shin SJ; Heo SJ; Kim CG; Lee MG; Beom SH; Lee CY; Lee JG; Kim DJ; Ahn JB
    Ann Surg Oncol; 2016 Mar; 23(3):928-35. PubMed ID: 26514121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study.
    Ohwada S; Ikeya T; Yokomori T; Kusaba T; Roppongi T; Takahashi T; Nakamura S; Kakinuma S; Iwazaki S; Ishikawa H; Kawate S; Nakajima T; Morishita Y
    Br J Cancer; 2004 Mar; 90(5):1003-10. PubMed ID: 14997197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uracil-tegafur as an adjuvant for hepatocellular carcinoma: a randomized trial.
    Hasegawa K; Takayama T; Ijichi M; Matsuyama Y; Imamura H; Sano K; Sugawara Y; Kokudo N; Makuuchi M
    Hepatology; 2006 Oct; 44(4):891-5. PubMed ID: 17006925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metronomic chemotherapy with tegafur-uracil following radical resection in stage II colorectal cancer.
    Chen TC; Jeng YM; Liang JT
    J Formos Med Assoc; 2021 May; 120(5):1194-1201. PubMed ID: 33023787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten-year survival of curability B gastric cancer patients treated by tegafur-uracil as postoperative adjuvant chemotherapy in a common public hospital: univariate and multivariate analyses.
    Okuyama T; Higashi T; Edagawa A; Nagata S; Hashimoto K; Saeki H; Oki E; Uchiyama H; Kawanaka H; Morita M; Tateishi M; Korenaga D; Yaita H; Takenaka K
    Fukuoka Igaku Zasshi; 2012 Jul; 103(7):138-44. PubMed ID: 22978066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.